Background: Enterobacter species has emerged as an important pathogen of nosocomial bacteremia. The purpose of this study is to review the clinical characteristics of bacteremia in pediatric patients. Materials and methods: We reviewed retrospectively the medical records of patients (under the age of 18 years) having Enterobacter bacteremia who were treated at Taipei the Veterans General Hospital from January 2001 to June 2011. Results: In total, 853 positive blood cultures were obtained from 620 patients during the study period. Among them, 96 episodes of Enterobacter bacteremia were found in 83 patients, accounting for 11.3% of all bacteremia. Eighty-two cases (98.8%) were nosocomial infections. Most of the cases were neonates (62 cases, 74.7%) and premature infants (51 cases, 61.5%). The common sources of bacteremia were the respiratory tract (53.0%), followed by intravascular catheter (10.8%), multiple sources (10.8%), and the gastrointestinal tract (8.4%). The overall case fatality rate was 18.1%, with the highest rate being reported among premature infants. The factors responsible for the deaths were leukocytosis and a higher median number of underlying diseases. Conclusion: Based on the findings of the present study, it can be concluded that Enterobacter species are probably an important pathogen of nosocomial bacteremia in premature neonates. The number of underlying diseases should be considered a major factor influencing the prognosis.
Introduction
Nosocomial bloodstream infections are important causes of morbidity and mortality worldwide. Enterobacter species, which are the normal members of the flora of the gastrointestinal tract, are significant pathogens for a variety of infections, such as pneumonia, urinary tract infections, wound infections, and bacteremia, especially in nosocomial infections. 1e3 In healthy children, Enterobacter species rarely cause any disease; however, in patients with underlying diseases, especially in premature patients, they are frequent pathogens involved in bacteremia.
3e5 Several risk factors of Enterobacter bacteremia are known, such as gastrointestinal disease, life-threatening infections, malignancies, prematurity, use of a central venous catheter, ventriculostomy, use of a ventriculoperitoneal shunt catheter, prolonged antibiotic therapy, parenteral nutrition, and immunosuppressive therapy. 6 According to a largescale survey conducted in the USA, Enterobacter cloacae accounted for 3.9% of all nosocomial bloodstream infections. 4 At the same time, a significant increase was observed in the antimicrobial resistance rates of E. cloacae. We conducted a retrospective study in order to review the clinical characteristics and antimicrobial susceptibility of Enterobacter bacteremia in pediatric patients.
Materials and methods
We reviewed retrospectively the medical records of patients under the age of 18 years, whose blood cultures yielded Enterobacter species, treated at the Taipei Veterans General Hospital between January 2001 and June 2011. Data were collected on age, sex, abnormal clinical findings [fever, poor activity, leukocytosis, leukopenia, and high Creactive protein (CRP) level], underlying illness, and type of infection. The presence of the following comorbid conditions was also documented: parenteral nutrition, corticosteroid use, immunosuppressant use, and invasive procedures.
Definitions
Enterobacter bacteremia was defined as the presence of Enterobacter species in one or more positive blood cultures collected during the hospitalization of these patients with corresponding clinical conditions. Only the first episode of Enterobacter bacteremia in each patient was considered as "one patient". Nosocomial infection was defined as an infection occurring after 72 hours of admission. Otherwise, bacteremia was considered to be community acquired. Polymicrobial bacteremia was defined as the isolation of multiple pathogens from the same culture (the same bottle of blood culture) or from different cultures (different bottles) but at the same time.
The source of infection was determined as one of the following: respiratory tract, intestinal, biliary tract, urinary tract, surgical wounds, intravascular catheter, or multiple or unknown sources, based on clinical signs and symptoms (e.g., fever, leukocytosis, leukopenia, poor activity, and high CRP level) of infection and organisms cultured from these possible sources. Bacteremia was considered to have originated from the lungs when a ventilator was used for a prolonged time or radiologic evidence of new-onset or progressing pneumonia was found with concomitant isolation of Enterobacter species from blood or sputum. Bacteremia of unknown origin was defined as bacteremia for which there was no documented distal source.
Empirical antibiotic treatment was considered appropriate when all isolated pathogens were susceptible to at least one of the administered agents and it was administered prior to the time of positive blood culture. However, empirical therapy was considered inappropriate when the isolate was nonsusceptible to the antimicrobial agents(s) administered or the patients were not prescribed antimicrobial agents on the day of the onset of bacteremia. 7 Recovery was defined as improvements in patients' clinical condition, such as becoming afebrile and having stable vital signs after the initiation of antibiotic therapy. Morbidity was considered when the patients had long time sequels which were directly related to bacteremia, despite appropriate antibiotic treatments. The case fatality rate was defined as the number of deaths among patients with bacteremia. Death was not considered directly because of other conditions being apparently documented as the cause of death; otherwise, the death was attributable to the bacteremia. Nonparametric data were expressed as median and range.
Microbiology
Blood samples of around 0.5e1.0 mL were collected under sterile conditions from peripheral punctures and injected directly into Baxtar blood culture bottles. These bottles were then incubated in BACTEC 9240, which is designed for the rapid detection of bacteria and fungi in clinical cultures of blood (Becton Dickinson Diagnostic Instrument Systems, Sparks, MD, USA), at 35.5 C. Antimicrobial susceptibility tests were carried out using the MicroScan AutoSCAN-4 data management system (Dade MicroScan Inc., West Sacramento, CA, USA).
Statistical analysis
Univariate analysis was performed to identify the possible risk factors associated with death attributable to Enterobacter bacteremia. The ManneWhitney U test, independent samples t test, and Fisher's exact test were used as appropriate. Statistical analysis was performed using IBM SPSS version 19 (SPSS Inc., Chicago, IL, USA). A p value of <0.05 was considered statistically significant.
Results
During the 10-year retrospective study period, 853 positive blood cultures were obtained from 620 pediatric patients. The most common pathogens of bacteremia were yeast, Staphylococcus aureus, and Staphylococcus epidermidis; Enterobacter ranked fourth, accounting for 11.3% of all types of bacteremia. E. cloacae was the most common species, accounting for 78 episodes (81.3%); followed by Enterobacter aerogenes, for 11 episodes (11.5%); Enterobacter sakazakii, for four episodes (4.2%); and Table 1 . There were 48 male and 35 female patients; the majority of patients were neonates (74.7%). Nosocomial infection was reported in 82 cases (98.8%), and one case (1.2%) was community acquired. Polymicrobial bacteremia (2 or 3 microorganisms) occurred in two cases (2.4%): Enterococcus faecalis (1), Escherichia coli (1), and E. aerogenes (1). Nearly all the patients (98.8%) received appropriate antibiotic treatment. All patients had major underlying conditions, with most of them having more than one condition ( Table 2 ). The most prominent underlying condition in patients with Enterobacter bacteremia was prematurity (51 cases, 61.4%), and the most prominent predisposing factors were central venous catheter use (75 cases, 90.4%) and prolonged antibiotic therapy (77 cases, 92.8%). c Neurological sequel (1 patient), endocarditis (1 patient), and respiratory failure (1 patient). CHD Z congenital heart disease; CRP Z C-reactive protein; NICU Z neonatal intensive care unit; PICU Z pediatric intensive care unit.
The respiratory tract (53.0%), intravascular catheter (10.8%), multiple sources (10.8%), gastrointestinal tract (8.4%), and genitourinary tract (8.4%) were the major sources of bacteremia. Other sources included surgical wounds (2.4%) and the biliary tract (1.2%). During the study period, most of the patients had two to three episodes of bacteremia caused by other microorganisms.
In this study, the overall case fatality rate was 18.1% (15/83). Death was attributed to E. cloacae bacteremia in 14 cases (93.3%) and E. aerogenes bacteremia in one case (6.7%). The prognostic factors, including clinical and laboratory factors, potentially related to deaths due to bacteremia in patients with Enterobacter species infection are shown in Table 3 . Factors that correlated significantly with a poor prognosis in the univariate analysis were leukocytosis >11,000 cells/mm 3 (p Z 0.030) and a higher median number of underlying diseases (p < 0.001).
Antimicrobial susceptibility to Enterobacter species isolated from blood culture is summarized in Table 4 (Fig. 2) .
Discussion
The incidence of nosocomial Enterobacter bacteremia is gradually increasing 7 and was reported to account for 10.9% of nosocomial infections in a study from Taiwan conducted in 1999. 8 Bonadio et al 9 reported that E. cloacae bacteremia was a relatively rare infection in pediatric population and the rate of isolation of this organism relative to all positive blood cultures was 0.6%. Other studies reported that Enterobacter bacteremia accounted for 5e6% of all bacteremia 6 and 8.7% cases of neonatal sepsis. 10 In our recent study, Enterobacter bacteremia was found to account for 11.3% of all bacteremia; based on the findings, c Congenital heart disease (10 patients), congenital anomalies (12 patients), pneumonia (8 patients), premature rupture of membrane (7 patients), respiratory failure (3 patients), asphyxia (1 patient), and herpetic gingivostomatitis (1 patient). Enterobacter sepsis is mostly a nosocomial infection, 11 and there is strong evidence to suggest that alterations in the gastrointestinal bacterial flora of hospitalized patients lead to the selection of virulent and frequently resistant strains of Enterobacter species, with a subsequent risk of infection. 12, 13 Several other studies have indicated that Enterobacter infections are particularly severe in children younger than 18 months.
14e16 Our study involved mostly neonates (74.7%) and premature infants (61.5%). Hervas et al 10 reported that the predisposing factors for nosocomial infections in patients of a neonatal intensive care unit (NICU) were mainly prematurity (57.7%) and respiratory problems (37.7%), which are similar to our results. All the patients in our study had an underlying illness and/or predisposing factors that are known to contribute to colonization of Enterobacter species, and our case fatality rate was 18.1%, in comparison with 21e24% reported in other series. 6, 14, 17 The US National Nosocomial Infections Surveillance System revealed that the common sources of E. cloacae bacteremia were (in the descending order) unknown (primary bacteremia), respiratory tract, genitourinary tract, intravascular catheter, wounds/surgery, gastrointestinal tract/abdomen, skin/soft tissue, biliary tract, and burns. 18 Another study reported that the most common portal of entry for pathogens was the gastrointestinal tract (39%), 19 but in our study, the most common source of infection was the respiratory tract (53.01%), which may be related to the invasive medical interventions and respiratory problems associated with prematurity. In our study, no significant difference in mortality was noted among patients who acquired bacteremia from different routes. We reported 82 cases (98.8%) of nosocomial Enterobacter bacteremia, which was higher than the rate reported in pediatric patients (57e67%) 9, 14 and in adult populations (72e84%).
20e24
Many factors favor the development of nosocomial infections in neonates. Nosocomial patients are always associated with an immunocompromised status, long-term hospitalization, and invasive procedures or surgeries. A substantial percentage of the patients were premature infants who had complications, especially respiratory distress and gastrointestinal diseases; underwent an invasive procedure (e.g., intubation or central venous catheter); received parenteral nutrition and prolonged antibiotics; and had a prolonged hospital stay. In the present study, the most common underlying disease associated with Enterobacter bacteremia was prematurity, followed by gastrointestinal disease. Although no single underlying disease was associated with mortality, a higher median number of underlying diseases was correlated significantly with poor prognosis in bacteremic patients. The number of underlying diseases should be considered as a major factor influencing the prognosis.
During the years 1992e1998, an increase in the resistance rate of Enterobacter to third-generation cephalosporins (from 22.2% to 59.2%) was observed in one study, which was related to the use of cefotaxime for empirical treatment of nosocomial infections in the NICU. 25 E. cloacae isolates in this study had high rates of resistance to cefuroxime (84.3%) and ceftriaxone (94.2%), which was similar to other study results. 26 Enterobacter readily develops resistance to second-and third-generation cephalosporins, and this is associated with the previous use of extended-spectrum cephalosporins. 20, 25 We observed a relatively high resistance rate of Enterobacter to second-and third-generation cephalosporins and to extended-spectrum penicillins; however, the lack of statistical significance may be attributed to the small number of cases. Widespread antimicrobial resistance now exists among Enterobacter strains, which has been reported to affect the clinical outcome of affected patients in some studies. 20, 25, 27 In the past decade, many studies have reported outbreaks caused by Enterobacter in neonatal settings, especially by multiple drug-resistant strains. 10, 19, 28 However, there are also studies suggesting that the emergence of resistant organisms and the use of corresponding antibiotics may be coincidental. 29 In conclusion, Enterobacter species are emerging nosocomial pathogens with increasing antimicrobial resistance. Our study includes a review of clinical characteristics of bacteremia in pediatric patients. Leukocytosis and a high median number of underlying diseases are significantly associated with death attributable to bacteremia. Inappropriate use of antibiotics and polymicrobials are not associated with mortality. The limitations of our study are its retrospective nature and small sample size. Therefore, additional studies are needed to explain further the characteristics of Enterobacter bacteremia.
